Literature DB >> 4736582

Reduction of antibody plaque-forming cells by allogeneic antilymphocyte serum.

G W Morgan, V M Esposito, W Jarboe.   

Abstract

Allogeneic mouse antilymphocyte serum effectively reduced the number of antibody plaque-forming cells after the natural antilytic property had been eliminated by dilution.

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4736582      PMCID： PMC422710          DOI： 10.1128/iai.7.3.504-506.1973

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  7 in total

1.  Immunosuppressive activity of allogeneic anti-lymphocyte serum in the rat.

Authors:  K Ono; C W DeWitt; J H Wallace; E S Lindsey
Journal:  Transplantation       Date:  1969-02       Impact factor: 4.939

2.  Immunosuppressive activity of mouse alloantibodies.

Authors:  I P Witz; N P Chiampi; N Kaliss
Journal:  Transplantation       Date:  1969-10       Impact factor: 4.939

3.  Further improvements in the plaque technique for detecting single antibody-forming cells.

Authors:  A J Cunningham; A Szenberg
Journal:  Immunology       Date:  1968-04       Impact factor: 7.397

4.  Characterization of cytotoxic isoantisera produced in R3 mice. I. Demonstration of antibodies against the theta-C3H isoantigen.

Authors:  M Schlesinger; D Hurvitz
Journal:  Transplantation       Date:  1969-02       Impact factor: 4.939

5.  Prolongation of skin homograft survival by mouse-anti-mouse thymocyte isoantiserum.

Authors:  R N Taub
Journal:  Transplant Proc       Date:  1969-03       Impact factor: 1.066

6.  Suppression of rabbit lymph node cells by rabbit anti-leucocyte serum demonstrated in vitro by the antibody plaque test.

Authors:  S Harris; T N Harris
Journal:  J Immunol       Date:  1966-03       Impact factor: 5.422

7.  Application of the 51Cr cytotoxicity technique to the analysis of human lymphocyte isoantigens.

Authors:  G N Rogentine; B A Plocinik
Journal:  Transplantation       Date:  1967-09-05       Impact factor: 4.939
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.